Panel discussion

Alira Health

Date:April 23, 2024
Room:Marriott Hotel

Panel title

How to Strengthen the Vital Link to Your Investors in Uncertain Times

Panel summary

In 2023, the negative financial environment combined with strong competition for funding resulted in a disconnect between investors and innovators, placing the entire value creation system at risk.

This panel will focus on practical solutions to restore the vital link between investors and innovators. The panelists will discuss how we can work together towards a more sustainable connection between biotech entrepreneurs and investors that helps navigate uncertainties.

Speaker information


Alexandra Wollersheim, Partner, Transaction Advisory Services


Ajla Hrle, Head of Life Sciences, ATHOS KG
Andrew Kozlov, Managing Director at 4Bio Capital
Sarah Holland, CBO, Cureteq AG and President, Swiss Licensing Group

Company profile

Alira Health is a global healthcare firm whose mission is to humanize healthcare and life sciences in partnership with patients. We provide consulting and clinical services enabled by technology and real-world evidence. From development to medical care, we complement the expertise of our pharma, biotech, and medtech clients with a full spectrum of services across their entire solutions lifecycle.

Further information

Follow us